biotech / news / / Medical Xpress
Cedars-Sinai investigators have identified a drug-like compound that prevents two proteins from working together to promote the growth of colorectal and liver.
Cedars-Sinai researchers identified a compound, C3, that disrupts GIT1 and MAT2B protein interaction.
KEY POINTS
- C3 slows cancer cell growth and induces cell death in colorectal and liver cancer models.
- GIT1 is overactive in many cancers, suggesting C3 could have broad therapeutic applications.
- The compound is in preclinical stages and will be refined for greater effectiveness.
COMPANIES
Summarized by Newsio from Medical Xpress. How we summarize →